Neilayan Sen to Treatment Outcome
This is a "connection" page, showing publications Neilayan Sen has written about Treatment Outcome.
Connection Strength
0.079
-
Neoadjuvant Interdigitated Chemoradiotherapy Using Mesna, Doxorubicin, and Ifosfamide for Large, High-grade, Soft Tissue Sarcomas of the Extremity: Improved Efficacy and Reduced Toxicity. Am J Clin Oncol. 2019 01; 42(1):1-5.
Score: 0.021
-
Clinical features and outcomes in young adults with oral tongue cancer. Am J Otolaryngol. 2019 Jan - Feb; 40(1):93-96.
Score: 0.021
-
Lung stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer in the very elderly (=80years old): Extremely safe and effective. J Geriatr Oncol. 2017 Sep; 8(5):351-355.
Score: 0.019
-
Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0-2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response. J Thorac Oncol. 2015 Oct; 10(10):1475-80.
Score: 0.017